Streetbeat News

Stock Prices

IZEA

IZEA announced a 1-for-4 reverse stock split to be effective on June 16, 2023. This action is aimed at increasing the stock price and reducing the number of outstanding shares.

Portfolio Pulse from Benzinga Newsdesk

June 15, 2023 | 1:00 pm

BLIN

BNGO

BVS

DHC

Insiders have recently made significant purchases in four penny stocks: Diversified Healthcare Trust (DHC), Bioventus (BVS), Bionano Genomics (BNGO), and Bridgeline Digital (BLIN). These transactions may indicate confidence in the companies' prospects.

Portfolio Pulse from Lisa Levin

June 15, 2023 | 12:56 pm

FXI

China plans to boost its agricultural facility construction to aid its economy, according to Bloomberg. This move is expected to benefit the iShares China Large-Cap ETF (FXI).

Portfolio Pulse from Benzinga Newsdesk

June 15, 2023 | 12:56 pm

AGR

CWEN

UGI

Three utilities stocks with over 4% dividend yields have been highlighted by Wall Street's most accurate analysts. UGI Corporation (NYSE:UGI) has a 5.22% dividend yield, Clearway Energy, Inc. (NYSE:CWEN) has a 5.10% dividend yield, and Avangrid, Inc. (NYSE:AGR) has a 4.63% dividend yield.

Portfolio Pulse from Lisa Levin

June 15, 2023 | 12:51 pm

NVDA

NVIDIA Corporation (NASDAQ:NVDA) shares climbed on Wednesday amid artificial intelligence (AI) optimism. Traders expect the stock to continue rising through Friday. NVIDIA shares have almost tripled year-to-date, gaining over 48% in the past month.

Portfolio Pulse from Priya Nigam

June 15, 2023 | 12:46 pm

LLY

VERV

Verve Therapeutics announced an exclusive research collaboration with Eli Lilly to advance Verve's preclinical stage in vivo gene editing program targeting lipoprotein. This partnership has led to an increase in Verve's stock price.

Portfolio Pulse from Benzinga Newsdesk

June 15, 2023 | 12:46 pm

ABBV

AbbVie announced positive top-line results from its Phase 3 COMMAND study, showing risankizumab achieved the primary endpoint of clinical remission at week 52, as well as key secondary endpoints in adult patients with moderately to severely active ulcerative colitis. The safety profile of risankizumab was consistent with previous studies, with no new safety risks observed.

Portfolio Pulse from Benzinga Newsdesk

June 15, 2023 | 12:45 pm

TSLA

Tesla's stock rose over 5% this week but faced resistance near the top of an upper gap, resulting in a hanging man candlestick, suggesting lower prices may be on the horizon. The stock has been in an uptrend since April 27, with its relative strength index at almost 87%, indicating it is overbought.

Portfolio Pulse from Melanie Schaffer

June 15, 2023 | 12:40 pm

MULN

Mullen Automotive's stock is trading higher after a letter to shareholders highlighted its $135 million cash position and belief that it's trading at a discount relative to its cash holdings. The company also mentioned its stock has declined 90% since March-end and has received $279 million in purchase orders from Randy Marion Automotive Group.

Portfolio Pulse from Adam Eckert

June 15, 2023 | 12:37 pm

NLS

Nautilus, Inc. (NYSE:NLS) has entered into a securities purchase agreement with an institutional investor for a registered direct offering of 4,098,362 shares at $1.22 per share, totaling $5 million. The offering is expected to close on June 20, 2023. In a concurrent private placement, the company will issue warrants to purchase up to 4,098,362 shares of common stock.

Portfolio Pulse from Benzinga Newsdesk

June 15, 2023 | 12:36 pm